These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38952279)

  • 1. Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease.
    Yang Q; Zou Y; Lang Y; Yang J; Wu Y; Xiao X; Qin C; Zhao Y; Liu F
    Ren Fail; 2024 Dec; 46(2):2369701. PubMed ID: 38952279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.
    Limkunakul C; de Boer IH; Kestenbaum BR; Himmelfarb J; Ikizler TA; Robinson-Cohen C
    J Diabetes Complications; 2019 Apr; 33(4):296-301. PubMed ID: 30795915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort.
    Hirano T; Satoh N; Kodera R; Hirashima T; Suzuki N; Aoki E; Oshima T; Hosoya M; Fujita M; Hayashi T; Ito Y
    J Diabetes Investig; 2022 Apr; 13(4):657-667. PubMed ID: 34665936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy.
    Yu D; Wang Z; Zhang X; Qu B; Cai Y; Ma S; Zhao Z; Simmons D
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3546-3554. PubMed ID: 34291804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.
    Duan JY; Duan GC; Wang CJ; Liu DW; Qiao YJ; Pan SK; Jiang DK; Liu Y; Zhao ZH; Liang LL; Tian F; Liu ZS
    BMC Nephrol; 2020 Apr; 21(1):115. PubMed ID: 32245423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease.
    Wang Y; Zhang J; Zhang J; Wu Y; Zhang R; Ren H; Cooper ME; Liu F
    Front Endocrinol (Lausanne); 2021; 12():670674. PubMed ID: 34393995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.
    Branch M; German C; Bertoni A; Yeboah J
    J Diabetes Complications; 2019 Jul; 33(7):468-472. PubMed ID: 31088728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between mortality and serum uric acid levels in non-diabetes-related chronic kidney disease: An analysis of the National Health and Nutrition Examination Survey, USA, 1999-2010.
    Lee CL; Tsai SF
    Sci Rep; 2020 Oct; 10(1):17585. PubMed ID: 33067501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study.
    Roumeliotis S; Roumeliotis A; Georgianos PI; Stamou A; Manolopoulos VG; Panagoutsos S; Liakopoulos V
    Oxid Med Cell Longev; 2021; 2021():2968869. PubMed ID: 34712380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
    Ren H; Zhao L; Zou Y; Wang Y; Zhang J; Wu Y; Zhang R; Wang T; Wang J; Zhu Y; Guo R; Xu H; Li L; Cooper ME; Liu F
    Ren Fail; 2021 Dec; 43(1):477-487. PubMed ID: 33685340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-linear association of triglyceride-glucose index with cardiovascular and all-cause mortality in T2DM patients with diabetic kidney disease: NHANES 2001-2018 retrospective cohort study.
    Zhang H; Wang L; Zhang Q; Song Y; Cai M; Bao J; Yu Q
    Lipids Health Dis; 2024 Aug; 23(1):253. PubMed ID: 39154178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
    Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Zerbini G; Lamacchia O; Nicolucci A; Pugliese G;
    BMC Med; 2021 Mar; 19(1):66. PubMed ID: 33715620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
    Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
    Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease.
    Li CH; Lee CL; Hsieh YC; Chen CH; Wu MJ; Tsai SF
    BMC Nephrol; 2022 Apr; 23(1):157. PubMed ID: 35459096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.